Q3 2024 saw strong financial and operational results, with adjusted EBITDA up 16% and net profit up 25.4% year-over-year. The company optimized its capital structure following the Sabesp acquisition, maintained cost discipline, and advanced in all segments, while addressing regulatory and market challenges.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.